| Literature DB >> 36010603 |
Nikola Palevich1, Paul H Maclean1, Paul M Candy1, Wendy Taylor1, Ivona Mladineo2, Mingshu Cao1.
Abstract
In nematodes that invade the gastro-intestinal tract of the ruminant, the process of larval exsheathment marks the transition from the free-living to the parasitic stages of these parasites. To investigate the secretome associated with larval exsheathment, a closed in vitro system that effectively reproduces the two basic components of an anaerobic rumen environment (CO2 and 39 °C) was developed to trigger exsheathment in one of the most pathogenic and model gastrointestinal parasitic nematodes, Haemonchus contortus (barber's pole worm). This study reports the use of multimodal untargeted metabolomics and lipidomics methodologies to identify the metabolic signatures and compounds secreted during in vitro larval exsheathment in the H. contortus infective third-stage larva (iL3). A combination of statistical and chemoinformatic analyses using three analytical platforms revealed a panel of metabolites detected post exsheathment and associated with amino acids, purines, as well as select organic compounds. The major lipid classes identified by the non-targeted lipidomics method applied were lysophosphatidylglycerols, diglycerides, fatty acyls, glycerophospholipids, and a triglyceride. The identified metabolites may serve as metabolic signatures to improve tractability of parasitic nematodes for characterizing small molecule host-parasite interactions related to pathogenesis, vaccine and drug design, as well as the discovery of metabolic biomarkers.Entities:
Keywords: Haemonchus contortus; exsheathment; helminth; lipidomics; metabolomics; parasite
Mesh:
Year: 2022 PMID: 36010603 PMCID: PMC9406637 DOI: 10.3390/cells11162525
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1Developmental life cycle of the parasitic nematode Haemonchus contortus.
Figure 2Overview of the experimental procedure and multimodal metabolomics workflow. Schematic diagram of the closed in vitro system that effectively reproduces the two basic components of an anaerobic rumen environment (CO2 and 39 °C) was used to trigger exsheathment (xL3) in H. contortus third-stage infective larvae (iL3) in O2-free CO2 saturated saline solution (left). Multi-modal metabolomics workflow and statistical analyses used to process data integrated from multiple analytical approaches through to pathway mapping (right).
Figure 3H. contortus infective larvae during in vitro exsheathment. Time series analysis of the exsheathment activity of H. contortus L3 using the anaerobic in vitro system. Mean of the total exsheathment percentage (±SEM) at each time point across replicates (n = 5). Significant (p < 0.001) exsheathment was obtained resulting in 75% and 100% of larvae exsheathing after 70 min and 5 h, respectively, post trigger exposure. No exsheathment activity was observed in the absence of anaerobic treatment conditions. Exsheathment up to 6 h post trigger application shown.
Figure 4Scanning electron micrographs of the exsheathment process in H. contortus. SEMs are shown for seven time points post incubation (t = 0, 2, 4, 7, 9, 10 and 25 min). Each image depicts the earliest observations of key morphological changes that occur during the exsheathment process and is representative of the larval population for each biological sample. Scale bars differ and have been adjusted according to magnification of each image.
Summary of Compounds Identified Across All Metabolomics Streams.
| Metabolite Class | Molecular Species | Platform | Isotopic Peak ( | Ion Type | Calc Mass | Rt * (min) | |
|---|---|---|---|---|---|---|---|
|
| |||||||
|
| Lysine | HP | 147.1128_15.79 | [M+H]+ | 147.1128 | 15.8 | Lysine biosynthesis (cel00300) and degradation (cel00310) |
| HN | 145.0982_15.78 | [M−H]− | 145.0972 | 15.8 | |||
| Glycine | HP | 76.0396_13.21 | [M+H]+ | 76.0398 | 13.2 | cel00260-Glycine, serine, and threonine metabolism | |
| Threonine | HP | 120.0654_12.76 | [M+H]+ | 120.0655 | 12.7 | ||
| Methionine | HP | 150.0583_10.57 | [M+H]+ | 150.0583 | 10.5 | cel00270-Cysteine and methionine metabolism | |
| CP | 150.0595_1.10 | [M+H]+ | 150.0583 | 1.08 | |||
| Alanine | HP | 90.0546_12.54 | [M+H]+ | 90.0549 | 12.5 | cel00250-Alanine, aspartate and glutamate metabolism | |
| Glutamic acid | HN | 146.0465_13.2 | [M−H]− | 146.0448 | 13.3 | ||
| Isoleucine | HP | 132.1030_10.12 | [M+H]+ | 132.1019 | 10.2 | Valine, leucine, and isoleucine degradation (cel00280) and biosynthesis (cel00290) | |
| CP | 132.1022_1.87 | [M+H]+ | 132.1019 | 1.76 | |||
| Leucine | HP | 132.1025_9.84 | [M+H]+ | 132.1019 | 9.8 | ||
| CP | 132.1027_1.73 | [M+H]+ | 132.1019 | 1.75 | |||
| Tryptophan | HP | 205.0969_10.45 | [M+H]+ | 205.0972 | 10.5 | cel00380-Tryptophan metabolism | |
| Phenylalanine | HP | 166.0877_9.80 | [M+H]+ | 166.0863 | 9.8 | cel00360-Phenylalanine metabolism | |
|
| Xanthine | HN | 151.0258_8.62 | [M−H]− | 151.0251 | 8.3 * | cel00230-Purine metabolism |
| CP | 153.0419_1.39 | [M+H]+ | 153.0407 | ||||
| Hypoxanthine | HP | 137.0470_8.24 | [M+H]+ | 137.0458 | 7.9 * | ||
| HN | 135.0309_8.24 | [M−H]− | 135.0301 | ||||
| CP | 137.0473_1.2 | [M+H]+ | 137.0458 | 1.2 | |||
|
| Piperidine | HP | 86.0963_9.84 | [M+H]+ | 86.097 | 10.3 ** | cel00310-Lysine degradation |
| Carnitine | HP | 162.1125_10.46 | [M+H]+ | 162.1125 | 10.6 ** | cel01212-Fatty acid metabolism | |
| CP | 162.1131_0.67 | [M+H]+ | 162.1125 | ||||
|
| |||||||
|
| Palmitic acid (16:0) | LN | 255.2327_3.5 | [M−H]− | 255.2319 | [ | cel00061-Fatty acid biosynthesis |
| Stearic acid (18:0) | LN | 283.2641_4.18 | [M−H]− | 283.2632 | |||
|
| DG(32:0) | LN | 603.4765_7.85 | [M+Cl]− | 603.475 | cel00561-Glycerolipid metabolism | |
| DG(34:0) | LN | 631.5075_8.56 | [M+Cl]− | 631.5063 | |||
| DG(36:0) | LN | 659.5388_9.23 | [M+Cl]− | 659.5376 | |||
| DG(18:0/18:0) MS2 | LP | 642.6033_9.98 | [M+NH4]+ | 642.6031 | |||
| DG(16:0/18:0) MS2 | LP | 614.5719_8.55 | [M+NH4]+ | 614.5718 | |||
|
| PKHdiA-PS | LN | 686.2696_6.46 | [M+Cl]− | 686.2703 | cel00564-Glycerophospholipid metabolism | |
| OHHdiA-PS | LN | 714.3014_7.23 | [M+Cl]− | 714.3016 | |||
|
| hydroxy-eicosenoic acid | LP | 344.3161_2.28 | [M+NH4]+ | 344.3159 | cel00590-Arachidonic acid metabolism | |
| 2-oxo-docosanoic acid | LP | 372.3473_2.88 | [M+NH4]+ | 372.3472 | cel01040-Biosynthesis of unsaturated fatty acids | ||
|
| TG(16:0/18:0/18:0) MS2 | LP | 880.8331_12.57 | [M+NH4]+ | 880.8328 | cel00561-Glycerolipid metabolism |
Metabolomics analysis was performed on samples (approximately 200,000 L3/sample with n = 5 biological replicates) containing 100% exsheathed H. contortus xL3 at 6 h post incubation. Compounds were identified by matching with a local library of authentic standards, public domain mass spectral databases, and analytical stream. Abbreviations: Rt, retention time in minutes; LPG, lysophosphatidylglycerol; DG, diglyceride; FA, fatty acyls; GP, glycerophospholipids; TG, triglycerides. All metabolite identifications are classed with Level 2 confidence for lipids with 16:0, 18:0, etc., referring to fatty acids with their respective number of carbon atoms and double bonds. rt *, standards as previously described [52]; rt **, QSRR prediction.